Sourav Dey
Research Subjects
Research Interests
Sourav Dey has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- David L. Katz
True Health Initiative
2 shared publications - David Miles Eisenberg
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
2 shared publications - Jason Carpenter
Manifold, Inc, Oakland, CA, United States
2 shared publications - Katherine Edwards
Better Therapeutics, San Francisco, California
2 shared publications - Kevin Appelbaum
Better Therapeutics, San Francisco, CA, USA
2 shared publications - Mark A. Berman
Better Therapeutics, Inc
2 shared publications
Latest Publications
- Open Access
- 12 March 2019
- Published by JMIR Publications Inc. in JMIR Cardio
- Vol. 3 (1) , e13030
Achieving Rapid Blood Pressure Control With Digital Therapeutics: Retrospective Cohort and Machine Learning Study
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Behavioral therapies, such as e-counseling and self-monitoring dispensed through mobile apps, have been shown to improve blood pressure but results vary and long-term engagement is a challenge. Machine learning is a rapidly advancing discipline that can be used to generate predictive and responsive models for the management and treatment of chronic conditions and shows potential for meaningfully improving outcomes. Objective: This retrospective analysis of data from the digital therapeutic, Better, examines its effect on blood pressure in hypertensive adults and explores the use of machine learning methods to predict intervention completion. Methods: The Better database was queried for participants with hypertension, who engaged with the intervention for at least 2 weeks and had paired blood pressure (BP) values. Participants were required to be ≥ 18 years old, reside in the United States and own a smartphone. The digital intervention offers personalized behavior therapy, including goal setting, skill building and self-monitoring. Participants reported BP at will. Changes in BP were calculated using averages of baseline and ending BP for each participant. Machine learning was used to generate a model of participants who would complete the intervention. Random forest models were trained at days 1, 3 and 7 of the intervention and the generalizability of the models was assessed using leave-one-out cross validation. Results: The primary analysis cohort was comprised of 172 hypertensive participants with paired BP values who were engaged with the intervention. Participants were 86.1% female, with a mean age of 55.0 years (95% CI 53.7, 56.2), baseline systolic blood pressure (SBP) of 138.9 mmHg (95% CI 136.6, 141.3) and diastolic (DBP) of 86.2 mmHg (95% CI 84.8, 87.7). Mean BP change was -11.5 mmHg for SBP and -5.9 mmHg for DBP over a mean of 62.6 days (P < .001). Amongst participants with Stage 2 Hypertension, mean BP change was -17.6 mmHg for SBP and -8.8 mmHg for DBP. Changes in BP remained significant in a mixed effects model accounting for baseline SBP, age, gender and BMI (P < .001). 43% of participants tracking BP at 12 weeks achieved the 2017 ACC/AHA definition of blood pressure control. The 7-day predictive model for intervention completion was trained on 429 participants and the AUC of the receiver operating characteristic was .72 with a false positive rate of 25%. Conclusions: The Better digital therapeutic was effective in lowering blood pressure among hypertensive adults. The degree of BP reduction was clinically meaningful and achieved rapidly by a majority of studied participants. Greater improvement was observed in participants with more severe hypertension at baseline. A successful proof of concept for using machine learning to predict intervention completion was presented
- 12 March 2019
- Published by JMIR Publications Inc. in JMIR Cardio
- Vol. 3 (1) , e13030
Open AccessAchieving Rapid Blood Pressure Control With Digital Therapeutics: Retrospective Cohort and Machine Learning Study
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Behavioral therapies, such as e-counseling and self-monitoring dispensed through mobile apps, have been shown to improve blood pressure but results vary and long-term engagement is a challenge. Machine learning is a rapidly advancing discipline that can be used to generate predictive and responsive models for the management and treatment of chronic conditions and shows potential for meaningfully improving outcomes. Objective: This retrospective analysis of data from the digital therapeutic, Better, examines its effect on blood pressure in hypertensive adults and explores the use of machine learning methods to predict intervention completion. Methods: The Better database was queried for participants with hypertension, who engaged with the intervention for at least 2 weeks and had paired blood pressure (BP) values. Participants were required to be ≥ 18 years old, reside in the United States and own a smartphone. The digital intervention offers personalized behavior therapy, including goal setting, skill building and self-monitoring. Participants reported BP at will. Changes in BP were calculated using averages of baseline and ending BP for each participant. Machine learning was used to generate a model of participants who would complete the intervention. Random forest models were trained at days 1, 3 and 7 of the intervention and the generalizability of the models was assessed using leave-one-out cross validation. Results: The primary analysis cohort was comprised of 172 hypertensive participants with paired BP values who were engaged with the intervention. Participants were 86.1% female, with a mean age of 55.0 years (95% CI 53.7, 56.2), baseline systolic blood pressure (SBP) of 138.9 mmHg (95% CI 136.6, 141.3) and diastolic (DBP) of 86.2 mmHg (95% CI 84.8, 87.7). Mean BP change was -11.5 mmHg for SBP and -5.9 mmHg for DBP over a mean of 62.6 days (P < .001). Amongst participants with Stage 2 Hypertension, mean BP change was -17.6 mmHg for SBP and -8.8 mmHg for DBP. Changes in BP remained significant in a mixed effects model accounting for baseline SBP, age, gender and BMI (P < .001). 43% of participants tracking BP at 12 weeks achieved the 2017 ACC/AHA definition of blood pressure control. The 7-day predictive model for intervention completion was trained on 429 participants and the AUC of the receiver operating characteristic was .72 with a false positive rate of 25%. Conclusions: The Better digital therapeutic was effective in lowering blood pressure among hypertensive adults. The degree of BP reduction was clinically meaningful and achieved rapidly by a majority of studied participants. Greater improvement was observed in participants with more severe hypertension at baseline. A successful proof of concept for using machine learning to predict intervention completion was presented
- Open Access
- 6 December 2018
- Published by JMIR Publications Inc. in JMIR Preprints
Achieving Rapid Blood Pressure Control With Digital Therapeutics: Retrospective Cohort and Machine Learning Study (Preprint)
BACKGROUND Behavioral therapies, such as electronic counseling and self-monitoring dispensed through mobile apps, have been shown to improve blood pressure, but the results vary and long-term engagement is a challenge. Machine learning is a rapidly advancing discipline that can be used to generate predictive and responsive models for the management and treatment of chronic conditions and shows potential for meaningfully improving outcomes. OBJECTIVE The objectives of this retrospective analysis were to examine the effect of a novel digital therapeutic on blood pressure in adults with hypertension and to explore the ability of machine learning to predict participant completion of the intervention. METHODS Participants with hypertension, who engaged with the digital intervention for at least 2 weeks and had paired blood pressure values, were identified from the intervention database. Participants were required to be ≥18 years old, reside in the United States, and own a smartphone. The digital intervention offers personalized behavior therapy, including goal setting, skill building, and self-monitoring. Participants reported blood pressure values at will, and changes were calculated using averages of baseline and final values for each participant. Machine learning was used to generate a model of participants who would complete the intervention. Random forest models were trained at days 1, 3, and 7 of the intervention, and the generalizability of the models was assessed using leave-one-out cross-validation. RESULTS The primary cohort comprised 172 participants with hypertension, having paired blood pressure values, who were engaged with the intervention. Of the total, 86.1% participants were women, the mean age was 55.0 years (95% CI 53.7-56.2), baseline systolic blood pressure was 138.9 mmHg (95% CI 136.6-141.3), and diastolic was 86.2 mmHg (95% CI 84.8-87.7). Mean change was –11.5 mmHg for systolic blood pressure and –5.9 mmHg for diastolic blood pressure over a mean of 62.6 days (P<.001). Among participants with stage 2 hypertension, mean change was –17.6 mmHg for systolic blood pressure and –8.8 mmHg for diastolic blood pressure. Changes in blood pressure remained significant in a mixed-effects model accounting for the baseline systolic blood pressure, age, gender, and body mass index (P<.001). A total of 43% of the participants tracking their blood pressure at 12 weeks achieved the 2017 American College of Cardiology/American Heart Association definition of blood pressure control. The 7-day predictive model for intervention completion was trained on 427 participants, and the area under the receiver operating characteristic curve was .78. CONCLUSIONS Reductions in blood pressure were observed in adults with hypertension who used the digital therapeutic. The degree of blood pressure reduction was clinically meaningful and achieved rapidly by a majority of the studied participants. Greater improvement was observed in participants with more severe hypertension at baseline. A successful proof of concept for using machine learning to predict intervention completion was presented.
- 6 December 2018
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessAchieving Rapid Blood Pressure Control With Digital Therapeutics: Retrospective Cohort and Machine Learning Study (Preprint)
BACKGROUND Behavioral therapies, such as electronic counseling and self-monitoring dispensed through mobile apps, have been shown to improve blood pressure, but the results vary and long-term engagement is a challenge. Machine learning is a rapidly advancing discipline that can be used to generate predictive and responsive models for the management and treatment of chronic conditions and shows potential for meaningfully improving outcomes. OBJECTIVE The objectives of this retrospective analysis were to examine the effect of a novel digital therapeutic on blood pressure in adults with hypertension and to explore the ability of machine learning to predict participant completion of the intervention. METHODS Participants with hypertension, who engaged with the digital intervention for at least 2 weeks and had paired blood pressure values, were identified from the intervention database. Participants were required to be ≥18 years old, reside in the United States, and own a smartphone. The digital intervention offers personalized behavior therapy, including goal setting, skill building, and self-monitoring. Participants reported blood pressure values at will, and changes were calculated using averages of baseline and final values for each participant. Machine learning was used to generate a model of participants who would complete the intervention. Random forest models were trained at days 1, 3, and 7 of the intervention, and the generalizability of the models was assessed using leave-one-out cross-validation. RESULTS The primary cohort comprised 172 participants with hypertension, having paired blood pressure values, who were engaged with the intervention. Of the total, 86.1% participants were women, the mean age was 55.0 years (95% CI 53.7-56.2), baseline systolic blood pressure was 138.9 mmHg (95% CI 136.6-141.3), and diastolic was 86.2 mmHg (95% CI 84.8-87.7). Mean change was –11.5 mmHg for systolic blood pressure and –5.9 mmHg for diastolic blood pressure over a mean of 62.6 days (P<.001). Among participants with stage 2 hypertension, mean change was –17.6 mmHg for systolic blood pressure and –8.8 mmHg for diastolic blood pressure. Changes in blood pressure remained significant in a mixed-effects model accounting for the baseline systolic blood pressure, age, gender, and body mass index (P<.001). A total of 43% of the participants tracking their blood pressure at 12 weeks achieved the 2017 American College of Cardiology/American Heart Association definition of blood pressure control. The 7-day predictive model for intervention completion was trained on 427 participants, and the area under the receiver operating characteristic curve was .78. CONCLUSIONS Reductions in blood pressure were observed in adults with hypertension who used the digital therapeutic. The degree of blood pressure reduction was clinically meaningful and achieved rapidly by a majority of the studied participants. Greater improvement was observed in participants with more severe hypertension at baseline. A successful proof of concept for using machine learning to predict intervention completion was presented.